NantHealth, Inc. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2016 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
NantHealth, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2016 to Q1 2023.
  • NantHealth, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $25K.
  • NantHealth, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$578K, a 863% decline from 2021.
  • NantHealth, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$60K, a 62.2% decline from 2020.
  • NantHealth, Inc. annual Deferred Income Tax Expense (Benefit) for 2020 was -$37K, a 93.4% increase from 2019.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $25K +$121K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 -$96K +$5K +4.95% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 -$101K +$126K +55.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q1 2020 -$227K -$391K -238% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $164K +$1.34M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 -$1.18M -$1.41M -605% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $233K +$5.12M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 -$4.89M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.